Vaccinex, Inc. Research and Development Expense
Vaccinex, Inc. (VCNX) reported Research and Development Expense of $12.54 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2025-04-15
- Vaccinex, Inc. research and development expense for the quarter ending 2024-12-31 was $2.13M, a 36.46% decline year-over-year.
- Vaccinex, Inc. research and development expense for the quarter ending 2024-09-30 was $3.17M, a 27.32% decline year-over-year.
- Vaccinex, Inc. research and development expense for the quarter ending 2024-06-30 was $3.86M, a 23.49% decline year-over-year.
- Vaccinex, Inc. research and development expense for the quarter ending 2024-03-31 was $3.38M, a 11.25% decline year-over-year.
- Vaccinex, Inc. research and development expense for fiscal 2024 was $12.54M, a 24.31% decline from fiscal 2023.
- Vaccinex, Inc. research and development expense for fiscal 2023 was $16.57M, a 18.56% increase from fiscal 2022.
- Vaccinex, Inc. research and development expense for fiscal 2022 was $13.98M, a 18.54% decline from fiscal 2021.
- Vaccinex, Inc. research and development expense for fiscal 2021 was $17.16M, a 20.37% decline from fiscal 2020.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $5.30M derived: sum of 2 quarters · filed 2025-04-15 | $9.16M derived: sum of 3 quarters · filed 2025-04-15 | $12.54M 10-K · filed 2025-04-15 |
| 2024-09-30 | $3.17M 10-Q · filed 2024-11-14 | $7.03M derived: sum of 2 quarters · filed 2024-11-14 | $10.41M 10-Q · filed 2024-11-14 | $13.77M derived: sum of 4 quarters · filed 2025-04-15 |
| 2024-06-30 | $3.86M 10-Q · filed 2024-08-14 | $7.25M 10-Q · filed 2024-08-14 | $10.60M derived: sum of 3 quarters · filed 2025-04-15 | $14.96M derived: sum of 4 quarters · filed 2025-04-15 |
| 2024-03-31 | $3.38M 10-Q · filed 2024-05-15 | $6.74M derived: sum of 2 quarters · filed 2025-04-15 | $11.10M derived: sum of 3 quarters · filed 2025-04-15 | $16.14M derived: sum of 4 quarters · filed 2025-04-15 |
| 2023-12-31 | $3.36M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $7.71M derived: sum of 2 quarters · filed 2025-04-15 | $12.76M derived: sum of 3 quarters · filed 2025-04-15 | $16.57M 10-K · filed 2025-04-15 |
| 2023-09-30 | $4.36M 10-Q · filed 2024-11-14 | $9.40M derived: sum of 2 quarters · filed 2024-11-14 | $13.22M 10-Q · filed 2024-11-14 | $16.96M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $5.05M 10-Q · filed 2024-08-14 | $8.86M 10-Q · filed 2024-08-14 | $12.60M derived: sum of 3 quarters · filed 2024-08-14 | $16.03M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $3.81M 10-Q · filed 2024-05-15 | $7.55M derived: sum of 2 quarters · filed 2024-05-15 | $10.98M derived: sum of 3 quarters · filed 2024-05-15 | $14.82M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $3.74M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-04-25 | $7.17M derived: sum of 2 quarters · filed 2024-04-25 | $11.01M derived: sum of 3 quarters · filed 2024-04-25 | $13.98M 10-K/A · filed 2024-04-25 |
| 2022-09-30 | $3.43M 10-Q · filed 2023-11-13 | $7.27M derived: sum of 2 quarters · filed 2023-11-13 | $10.24M 10-Q · filed 2023-11-13 | $14.19M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $3.84M 10-Q · filed 2023-08-14 | $6.81M 10-Q · filed 2023-08-14 | $10.76M derived: sum of 3 quarters · filed 2023-08-14 | $14.39M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $2.97M 10-Q · filed 2023-05-15 | $6.92M derived: sum of 2 quarters · filed 2023-05-15 | $10.55M derived: sum of 3 quarters · filed 2023-05-15 | $14.61M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $7.58M derived: sum of 2 quarters · filed 2023-03-31 | $11.65M derived: sum of 3 quarters · filed 2023-03-31 | $17.16M 10-K · filed 2023-03-31 |
| 2021-09-30 | $3.63M 10-Q · filed 2022-11-14 | $7.69M derived: sum of 2 quarters · filed 2022-11-14 | $13.21M 10-Q · filed 2022-11-14 | $17.45M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $4.06M 10-Q · filed 2022-08-15 | $9.58M 10-Q · filed 2022-08-15 | $13.83M derived: sum of 3 quarters · filed 2022-08-15 | $21.16M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $5.51M 10-Q · filed 2022-05-16 | $9.76M derived: sum of 2 quarters · filed 2022-05-16 | $17.10M derived: sum of 3 quarters · filed 2022-05-16 | $21.65M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $11.58M derived: sum of 2 quarters · filed 2022-03-31 | $16.14M derived: sum of 3 quarters · filed 2022-03-31 | $21.55M 10-K · filed 2022-03-31 |
| 2020-09-30 | $7.33M 10-Q · filed 2021-11-08 | $11.89M derived: sum of 2 quarters · filed 2021-11-08 | $17.30M 10-Q · filed 2021-11-08 | $21.71M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $4.56M 10-Q · filed 2021-08-16 | $9.97M 10-Q · filed 2021-08-16 | $14.38M derived: sum of 3 quarters · filed 2021-08-16 | $20.92M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $5.41M 10-Q · filed 2021-05-17 | $9.82M derived: sum of 2 quarters · filed 2021-05-17 | $16.36M derived: sum of 3 quarters · filed 2021-05-17 | $23.67M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $10.95M derived: sum of 2 quarters · filed 2021-03-31 | $18.26M derived: sum of 3 quarters · filed 2021-03-31 | $25.67M 10-K · filed 2021-03-31 |
| 2019-09-30 | $6.54M 10-Q · filed 2020-11-13 | $13.85M derived: sum of 2 quarters · filed 2020-11-13 | $21.26M 10-Q · filed 2020-11-13 | $28.33M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $7.30M 10-Q · filed 2020-08-14 | $14.72M 10-Q · filed 2020-08-14 | $21.79M derived: sum of 3 quarters · filed 2020-08-14 | $27.10M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $7.41M 10-Q · filed 2020-05-14 | $14.48M derived: sum of 2 quarters · filed 2020-05-14 | $19.80M derived: sum of 3 quarters · filed 2020-05-14 | $25.31M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $7.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $12.39M derived: sum of 2 quarters · filed 2020-03-09 | $17.90M derived: sum of 3 quarters · filed 2020-03-09 | $22.35M 10-K · filed 2020-03-09 |
| 2018-09-30 | $5.31M 10-Q · filed 2019-11-12 | $10.83M derived: sum of 2 quarters · filed 2019-11-12 | $15.28M 10-Q · filed 2019-11-12 | $20.31M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $5.51M 10-Q · filed 2019-08-14 | $9.97M 10-Q · filed 2019-08-14 | $14.99M derived: sum of 3 quarters · filed 2019-08-14 | $19.29M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $4.45M 10-Q · filed 2019-05-15 | $9.48M derived: sum of 2 quarters · filed 2019-05-15 | $13.77M derived: sum of 3 quarters · filed 2019-05-15 | $17.17M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $5.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $9.32M derived: sum of 2 quarters · filed 2019-03-13 | $12.71M derived: sum of 3 quarters · filed 2019-03-13 | $16.55M 10-K · filed 2019-03-13 |
| 2017-09-30 | $4.29M 10-Q · filed 2018-11-13 | $7.68M derived: sum of 2 quarters · filed 2018-11-13 | $11.52M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $3.39M 10-Q · filed 2018-08-14 | $7.23M 10-Q · filed 2018-08-14 |